Physician profile
Sanjay Kumar
NPI 1437120920
$2,892.38
in general payments reported to CMS, 2019-2025
43 companies · $706 in 2025
The $706 reported for 2025 was more than what 79% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $348 · 2020: $298 · 2021: $456 · 2022: $384 · 2023: $444 · 2024: $257 · 2025: $706.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,407.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,406.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $240.55 | 2019-2024 | |
| Otsuka America Pharmaceutical, INC. | $229.88 | 2023-2025 | Rexulti, Nuedexta |
| Abbott Laboratories | $184.53 | 2023-2025 | Freestyle Libre 3 |
| Novartis Pharmaceuticals Corporation | $175.69 | 2020-2024 | |
| Lilly USA, LLC | $151.48 | 2019-2025 | Kisunla, Trulicity |
| Amarin Pharma, INC. | $148.30 | 2019 | |
| Angiodynamics, INC. | $141.65 | 2023 | Auryon Laser System 100-120 Vac |
| Xeris Pharmaceuticals, INC. | $133.51 | 2022-2025 | Gvoke Hypopen |
| Silk Road Medical, INC. | $122.04 | 2023 | Enroute Transcarotid Stent, Enroute Transcarotid Neuroprotection System |
| Becton, Dickinson and Company | $120.81 | 2024 | Phasix Mesh |
| Medtronic, INC. | $102.88 | 2022 | |
| Corcept Therapeutics | $98.43 | 2025 | Korlym |
| Teva Pharmaceuticals USA, INC. | $84.72 | 2020-2025 | Austedo Xr, Austedo Xr |
| Boston Scientific Corporation | $82.55 | 2020 | |
| Acadia Pharmaceuticals INC | $74.21 | 2019-2022 |
Show all 43 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sanjay Kumar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.